Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Agilent Technologies's
Operating Income
for the
three
months ended in Jan. 2025 was $376 Mil. Agilent Technologies's Interest Expense for the
three
months ended in Jan. 2025 was $-28 Mil.
Agilent Technologies's interest coverage for the quarter that ended in Jan. 2025 was 13.43.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Agilent Technologies's Interest Coverage or its related term are showing as below:
A'
s Interest Coverage Range Over the Past 10 Years
Min: 7.91 Med: 12.39 Max: 19.26
Current: 14.51
A's Interest Coverage is ranked better than 57.58% of 99
companies
in the Medical Diagnostics & Research industry
Industry Median: 11.31
vs A: 14.51
Agilent Technologies Interest Coverage Historical Data
The historical data trend for Agilent Technologies's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Competitive Comparison of Agilent Technologies's Interest Coverage
For the Diagnostics & Research subindustry, Agilent Technologies's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies's Interest Coverage Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Agilent Technologies Interest Coverage Related Terms
Thank you for viewing the detailed overview of Agilent Technologies's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
A has been successfully added to your 